RxDoctor Payments Data

Rosanne Iversen, MD

Family Medicine · Steamboat Springs, CONPI 1881612778

Payments from drug & device makers

$2,263in general payments, 2019–2025

Across 98 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$817
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$247
  • Novo Nordisk$153
  • Otsuka America Pharmaceutical, Inc.$152
  • Biohaven Pharmaceuticals, Inc.$128
  • Vanda Pharmaceuticals Inc.$122
  • plus $645 from 17 others

What the payments were for

  • Food & beverage$2,263100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,263 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$174,568
Medicare patients
111
Services billed
4,708

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$18,256
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$9,631
XareltoRivaroxaban12$6,231
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,255
Gabapentin61$700
Levothyroxine Sodium52$669
Pregabalin19$542
Rosuvastatin Calcium39$534
Escitalopram Oxalate30$446
Atorvastatin Calcium42$395
Montelukast Sodium17$336
Bupropion XlBupropion Hcl24$334
Losartan Potassium27$327
Buspirone Hcl12$300
Metformin Hcl42$269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$18,25626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Steamboat Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →